FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

111051000001103: Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1141041000001114 Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    1143491000001112 Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Has specific active ingredient Medroxyprogesterone acetate false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Has specific active ingredient Conjugated estrogen false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route false Inferred relationship Existential restriction modifier
    Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Is a Product containing conjugated estrogen and medroxyprogesterone false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Premique tablets (Necessity Supplies Ltd) Is a False Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Inferred relationship Existential restriction modifier
    Premique tablets (PI) (Waymade Ltd) Is a False Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Inferred relationship Existential restriction modifier
    Premique tablets (PI) (Dowelhurst Ltd) Is a False Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Inferred relationship Existential restriction modifier
    Premique tablets (Sigma Pharmaceuticals Plc) Is a False Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Inferred relationship Existential restriction modifier
    Premique tablets (Lexon (UK) Ltd) Is a False Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Inferred relationship Existential restriction modifier
    Medroxyprogesterone 5mg / Conjugated oestrogens 625microgram tablets 84 tablet Has VMP False Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Inferred relationship Existential restriction modifier
    Premique tablets (Wyeth Laboratories) Is a False Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Inferred relationship Existential restriction modifier
    Premique tablets (Doncaster Pharmaceuticals Ltd) Is a False Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start